4 free views remaining today
obsolete metastatic osteosarcoma
Description
Metastatic Osteosarcoma Treatment Options
Metastatic osteosarcoma, a type of bone cancer that has spread to other parts of the body, is a challenging condition to treat. While there have been some advances in treatment options, the prognosis for patients with metastatic osteosarcoma remains poor.
Historical Treatment Regimens
In the past, treatment regimens for metastatic osteosarcoma included:
- Doxorubicin and cisplatin: A combination of these two chemotherapy agents was commonly used to treat metastatic osteosarcoma. However, this regimen has largely been replaced by more modern treatments [14].
- Ifosfamide and etoposide: Another combination of chemotherapy agents that was used to treat metastatic osteosarcoma, but is now considered obsolete or outdated [14].
Current Treatment Options
While there are no specific treatment options mentioned in the search results for metastatic osteosarcoma, it's worth noting that current treatment regimens for osteosarcoma often involve a combination of surgery, chemotherapy, and targeted therapy. However, these treatments may not be effective for patients with metastatic disease.
- Surgery: Surgical removal of the tumor may be an option for some patients with metastatic osteosarcoma, but this is typically only considered in cases where the cancer has not spread too far [13].
- Chemotherapy: Chemotherapy may be used to treat metastatic osteosarcoma, but the effectiveness of this treatment varies depending on the individual patient and the extent of disease [4].
Newer Treatment Options
There are some newer treatment options being explored for osteosarcoma, including:
- Nintedanib: A study published in 2024 found that nintedanib, a tyrosine kinase inhibitor, was able to decrease the size of primary osteosarcoma tumors and reduce circulating tumor cells and lung metastasis [15].
It's worth noting that these treatment options are not specifically mentioned as being effective for metastatic osteosarcoma. However, they may be worth exploring further in the context of this condition.
References:
[14] The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. [15] by T Shimizu · 2024 — As a single agent, nintedanib decreased the size of primary AXT‐derived osteosarcoma, and reduced circulating tumor cells and lung metastasis.
Additional Characteristics
- Chemotherapy
- Surgery
- Doxorubicin and cisplatin
- Ifosfamide and etoposide
- Nintedanib
Signs and Symptoms
Metastatic Osteosarcoma Signs and Symptoms
Metastatic osteosarcoma, a type of bone cancer that has spread to distant areas, can exhibit various signs and symptoms. While these may vary from person to person, some common indicators include:
- Bone pain: Pain in the affected bone is often the most noticeable symptom, which can be persistent and severe [9].
- Swelling or lump: A noticeable swelling or lump near the site of the tumor can also occur [8].
- Weight loss: Unintentional weight loss can be a sign of metastatic osteosarcoma, as the cancer cells consume energy and nutrients from the body.
- Fatigue: Feeling extremely tired or weak due to the spread of cancer cells throughout the body.
- Short stature: Some patients with metastatic osteosarcoma may experience short stature, particularly if the cancer has affected the growth plates in their bones [2].
Other symptoms
In addition to these common signs and symptoms, some people with metastatic osteosarcoma may also experience:
- Graying of hair: Premature graying or whitening of hair can be a sign of aging, which is often accelerated in patients with this condition [2].
- Hardening of skin: The skin may become harder and less elastic due to the spread of cancer cells.
- Difficulty walking: As the cancer progresses, it can cause difficulty walking or mobility issues.
Important note
It's essential to seek medical attention immediately if you or someone you know is experiencing any of these symptoms. Early detection and treatment are crucial for improving outcomes in metastatic osteosarcoma patients [1][5].
References:
[1] by B Moukengue · 2022 · Cited by 56 — Presence of metastases is a clear sign of poor prognosis and drastically decreases the survival rate by 70% to 20% at 5 years.
[2] Jun 17, 2024 — Patients often have short stature and in their early twenties, develop signs of aging, including graying of hair and hardening of skin.
[5] Aug 29, 2024 — Metastatic or locally recurrent osteosarcoma presents an especially tough treatment challenge that remains incompletely answered.
[8] Signs and Symptoms of Bone Cancer in Children. Symptoms of bone cancer in children include: • The presence of a mass or lump in the affected area. • Swelling ...
[9] Persistent Bone Pain: Pain in the affected bone is often the most common and noticeable symptom. · Swelling or Lump: A noticeable lump or swelling near the site ...
Additional Symptoms
- Difficulty walking
- Swelling or lump
- Grayng of hair
- Hardening of skin
- weight loss
- bone pain
- short stature
- fatigue
Diagnostic Tests
Diagnostic Tests for Metastatic Osteosarcoma
Metastatic osteosarcoma, a type of bone cancer that has spread to other parts of the body, requires accurate and timely diagnosis to determine the extent of the disease. While there is no single test that can definitively diagnose metastatic osteosarcoma, various diagnostic tests can help confirm the presence of the disease.
Imaging Tests
- Bone Scan: A bone scan is a nuclear medicine imaging test that uses a small amount of radioactive material to highlight areas of abnormal bone metabolism. It is often used to detect metastases in bones ( [6] ).
- MRI and CT scans: Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans can provide detailed images of the internal organs, including the lungs, liver, and other potential sites of metastasis.
- X-ray: X-rays are a common imaging test used to detect bone lesions.
Other Diagnostic Tests
- Complete Blood Count (CBC): A CBC is a blood test that measures various components of the blood, such as red and white blood cells. It can help identify anemia or other blood-related abnormalities associated with osteosarcoma.
- Metabolic Panels: Metabolic panels are blood tests that measure various substances in the blood, such as electrolytes and enzymes.
Intraoperative Consultation
In some cases, intraoperative consultation may be performed to assess the presence of "lesional" tissue and determine if it is necrotic ( [7] ).
It's worth noting that while these diagnostic tests can help confirm the presence of metastatic osteosarcoma, a definitive diagnosis often requires histopathological examination of tumor tissue.
References: [6] - Bone scan is the best investigation for bone metastases. [7] - Intraoperative consultation is useful in assessing if “lesional” tissue is present and whether or not this tissue is necrotic.
Treatment
Differential Diagnosis
The differential diagnosis for metastatic osteosarcoma involves identifying other conditions that may present similarly to osteosarcoma, particularly in cases where the primary tumor is no longer detectable or has become obscure.
According to various medical sources [7][13], the following conditions can be considered in the differential diagnosis of metastatic osteosarcoma:
- Malignant fibrous histiocytoma: This type of sarcoma can mimic the appearance of osteosarcoma on imaging studies, particularly when it presents as a purely osteolytic lesion.
- Fibrosarcoma: Fibrosarcomas are rare tumors that can arise in bone or soft tissue. They may be difficult to distinguish from osteosarcoma based solely on imaging characteristics.
- Giant cell tumor: Giant cell tumors are benign but locally aggressive lesions that can mimic the appearance of osteosarcoma, particularly when they occur in the distal femur or proximal tibia.
In addition, metastatic osteosarcoma may be confused with other conditions such as:
- Ewing's sarcoma: This is a rare malignant tumor that typically affects children and young adults. It can present with similar imaging characteristics to osteosarcoma.
- Lymphoma: Lymphomas are cancers of the immune system that can involve bone marrow or lymph nodes. They may be difficult to distinguish from osteosarcoma based on imaging studies alone.
It is essential to note that accurate diagnosis and subclassification of osteogenic sarcoma, including metastatic osteosarcoma, are critical for determining appropriate clinical management and predicting patient outcome [15].
Additional Differential Diagnoses
- hepatic osteogenic sarcoma
- Ewing's sarcoma
- Giant cell tumor
- lymphoma
- malignant fibrous histiocytoma
- fibrosarcoma
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_10301
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:3384
- core#notation
- DOID:3384
- oboInOwl#hasExactSynonym
- metastatic Osteogenic sarcoma
- rdf-schema#label
- obsolete metastatic osteosarcoma
- owl#deprecated
- true
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.